Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
17 studies found for:    SLC2A4
Show Display Options
Rank Status Study
1 Completed Exercise Training and Glucose Metabolism in Aging
Conditions: Type 2 Diabetes Mellitus;   Impaired Glucose Tolerance (Prediabetes)
Interventions: Behavioral: Aerobic exercise training;   Behavioral: Detraining (cessation of exercise)
2 Unknown  Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation
Condition: Hearing Loss
Intervention: Drug: Proton pump inhibitor
3 Unknown  Prevalence of POU4F3 and SLC17A8 Mutations
Condition: Genetic Deafness
Intervention: Genetic: SLC17A8 et POU4F3 mutations genes analysis
4 Enrolling by invitation Mobile Health Technology as an Intervention for Diabetes Self-Management
Condition: Type II Diabetes Mellitus
Intervention: Other: Participation in Care4Life
5 Completed Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)
Conditions: Attention Deficit Disorder With Hyperactivity;   Methylphenidate;   Pharmacogenetics
Intervention: Genetic: norepinephrine transporter polymorphism,
6 Recruiting An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
Condition: Non-small Cell Lung Cancer (NSCLC)
Intervention: Drug: LDK378
7 Recruiting Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours
Condition: Solid Tumours
Intervention: Drug: SLC-0111
8 Unknown  Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
9 Completed Predicting Medication Response in Obsessive Compulsive Disorder
Condition: Obsessive Compulsive Disorder
Interventions: Drug: clomipramine;   Drug: escitalopram;   Drug: duloxetine
10 Recruiting TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Imatinib/Nilotinib
11 Recruiting Blood Pressure Response to Sodium in the Diet
Condition: Hypertension
Intervention: Other: High sodium diet and low sodium diet
12 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
13 Completed 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
Condition: Alzheimer Disease
Intervention: Drug: xaliproden (SR57746A)
14 Completed Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities
Condition: PTSD
Intervention: Drug: Paroxetine
15 Completed Further Studies of Attention Deficit Disorder - Residual Type (RT)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: methylphenidate;   Drug: placebo
16 Active, not recruiting Study Of Telemedicine Consultation at Home For Older Adults
Conditions: Physical Disorders;   Telemedicine
Intervention: Other: Telemedicine care
17 Completed
Has Results
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
Conditions: Depression;   Anxiety

Indicates status has not been verified in more than two years